Rani Therapeutics Holdings Inc
The RANI stock trades on Nasdaq All Markets
Company Description
The concept for Rani was developed by Mir Imran, a prolific medical inventor and entrepreneur who has founded more than twenty life sciences companies. Rani was established as a company after several years as a research project within InCube Labs, Mir’s multi-disciplinary life sciences lab focused on developing and commercializing breakthrough innovations. Our mission is to improve the lives of millions of patients suffering from chronic conditions by replacing painful injections with a pill designed to minimize GI discomfort.
Technology
Rani’s “robotic” pill incorporates a number of innovations, enabling it to navigate through the stomach and enter the small intestine. There, the RaniPill™ capsule injects the drug into the intestinal wall – where there are no sharp pain receptors, so the injection is painless.
With deep experience in engineering and material science, we designed the RaniPill™ capsule to ensure that the drug stays protected within the pill until injected.
The RaniPill™capsule moves through the stomach – where acids typically break down drugs – intact and then reaches the intestine where it delivers the drug into the intestinal wall. The highly vascularized intestinal wall allows the drug to be absorbed rapidly.
With deep experience in engineering and material science, we designed the RaniPill™ capsule to ensure that the drug stays protected within the pill until injected.
The RaniPill™capsule moves through the stomach – where acids typically break down drugs – intact and then reaches the intestine where it delivers the drug into the intestinal wall. The highly vascularized intestinal wall allows the drug to be absorbed rapidly.
Drug Pipeline
Source: Rani Therapeutics Holdings Inc - 20221129
Asset
Indication
Pre-Clinical
Ph1
Ph2
Ph3
Reg/Com
Phase
RT-101
Acromegaly
Phase 1
Neuroendocrine Tumors
Phase 1
RT-102
Osteoporosis
Phase 1
RT-104
Type 2 Diabetes
Preclinical
RT-105
Psoriatic Arthritis
Preclinical
RT-106
Type 2 Diabetes
Preclinical
0 Comments on RANI stock
Newest
Conversation